"10.1371_journal.pone.0065468","plos one","2013-06-06T00:00:00Z","Qing Yu; Arpana Sali; Jack Van der Meulen; Brittany K Creeden; Heather Gordish-Dressman; Anne Rutkowski; Sree Rayavarapu; Kitipong Uaesoontrachoon; Tony Huynh; Kanneboyina Nagaraju; Christopher F Spurney","Center for Genetic Medicine Research, Childrens National Medical Center, Washington DC, United States of America; Division of Cardiology, Childrens National Medical Center, Washington DC, United States of America; Kaiser SCPMG, Cure CMD, Olathe, Kansas, United States of America","Conceived and designed the experiments: QY AR KN CFS. Performed the experiments: QY AS JVDM BKC SR KU TH. Analyzed the data: QY AS JVDM BKC HGD CFS SR KU TH. Contributed reagents/materials/analysis tools: QY AS JVDM BKC CFS KN SR KU TH. Wrote the paper: QY HGD AR KN CFS.","The authors have the following interests. Omigapil was provided by Santhera Pharmaceuticals (Liestal, Switzerland). Thomas Meier, Chief Executive Officer for Santhera Pharmaceuticals provided comments on the manuscript. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","06","Qing Yu","QY",11,TRUE,4,7,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
